Kenya received its first batch of 21,000 doses on Tuesday through a deal with lenacapavir's manufacturer, Gilead Sciences, and the Global Fund to Fight AIDS. "The first phase of implementation will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results